ADAR1 edits METTL3 mRNA and changes its binding site to miR532-5p, leading to increased METTL3 protein, which further targets ARHGAP5, recognized by YTHDF1 to promote the proliferation, migration, and invasion of BC cells. The gene discussed is METTL3; the disease is breast cancer.